ADPT Stock Price History and Quote Analysis: Insights for Investors

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ADPT shares is 248, representing 99.27% of the company's common stock.

NIKKO ASSET MANAGEMENT AMERICAS, INC., in the last quarter, reduced its stake in ADPT by -5.14% restricting it's holding to 6.18 million shares of worth nearly $19.77M. SUMITOMO MITSUI TRUST HOLDINGS, INC. also lessened -5.14% of the ADPT shares from its portfolio, reducing its holding to 6.18 million shares of worth $19.83M. ARK INVESTMENT MANAGEMENT LLC also shunned ADPT shares holding by -17.53% last quarter which brought its holding to 10.56 million shares worth $33.90M.

As per its latest 13F filing, RUBRIC CAPITAL MANAGEMENT LP increased its stake in ADPT by 266.78% in the last quarter. The institutional holder raised its holding to 10.5 million shares having worth more than $33.71M. JENNISON ASSOCIATES LLC also added 22.03% more shares of ADPT to its portfolio, raising its holding to 174.77 thousand shares of worth $561.00K. RHUMBLINE ADVISERS also increased its ADPT shares holding by 2.53% which brought its holding to 173.86 thousand shares worth $558.06K.

The insider with the most stakes in ADPT is ROBINS CHAD M , CEO and Chairman at the company. Additionally, ADPT stock is highly held by Chief Financial Officer PETERSON TYCHO and President RUBINSTEIN JULIE among others.

Company executives, directors, and other insiders own 1.92% percent of Adaptive Biotechnologies Corporation's stock. Within the last six months, there have been 1 transaction(s) in which ADPT insiders have sold stock, totaling 26.92K shares. Insiders that have sold shares include TAYLOR STACY L, BOBULSKY SUSAN, and PISKEL KYLE.

There have been 0 transaction(s) during the past 6-months in which Adaptive Biotechnologies Corporation insiders have bought stock, totalling 0 shares

Around 139.37K Adaptive Biotechnologies Corporation shares are held by insiders, which represents about 1.92% of ADPT stock.

ADPT CEO and Chairman, ROBINS CHAD M holds the largest portfolio of the company's shares. ADPT shares owned by ROBINS total nearly 2.58 million.

NIKKO ASSET MANAGEMENT AMERICAS, INC. is the largest institutional owner in ADPT which holds 6.18 million shares worth $19.77M or 4.24% of the total ADPT shares outstanding followed by SUMITOMO MITSUI TRUST HOLDINGS, INC. with ownership of 6.18 million shares representing 4.24% of the ADPT ownership. RUBRIC CAPITAL MANAGEMENT LP is the third largest stakeholder with 10.5 million shares or 7.2% of the ownership worth more than $33.71M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ADPT is concerned, it is a stock which is optionable.

Number of ADPT shares short is 9.71M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 147.47M shares of ADPT are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ADPT has 76.82M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ADPT is 7.28.